Intraoperative hypotension is a common and potentially deleterious event in elderly patients undergoing spinal anaesthesia for repair of hip fractures. The synergism between intrathecal opioids and local anaesthetics may allow a reduction in the dose of local anaesthetic and cause less sympathetic block and hypotension, while still maintaining adequate anaesthesia. We studied 40 elderly patients having either an insertion of a dynamic hip screw or a hemiarthroplasty and compared 9.0 mg glucose-free bupivacaine with added fentanyl 20 µg (group BF) with 11.0 m glucose-free bupivacaine alone (group B). Hypotension was defined as a fall in systolic blood pressure to less than 75% baseline or less than 90 mmHg. The incidence and frequency of hypotension in group BF were less than in group B. Similarly, falls in systolic, diastolic and mean blood pressures were all less in group BF than in group B. However, there were four failed blocks in group BF and one in group B.
Hypotension is common in elderly patients undergoing hip fracture surgery under spinal anaesthesia with an incidence of over 50% in some studies 1 . The main cause of hypotension is sympathetic block with the associated decrease in systemic vascular resistance 2 . Hypotension may be deleterious because elderly patients have decreased physiological reserve and an increased incidence of systemic disease 1 .
Animal studies have shown that opioids and local anaesthetics combined have a synergistic effect intrathecally 3 . In humans, the addition of an opioid to a local anaesthetic spinal solution has allowed a reduction in the dose of local anaesthetic for elective orthopaedic, gynaecological and obstetric surgery.
In hip fracture surgery under spinal anaesthesia, many studies have investigated the use of fluids and vasopressors to treat hypotension, but few studies have examined ways to avoid it. In this study we compared the effects of a solution of 11.0 mg glucose-free bupivacaine alone, to a solution of 9.0 mg glucosefree bupivacaine and 20 µg fentanyl. Local experience indicated that both these solutions provided adequate anaesthesia for surgery. In effect we investigated both the difference in hypotension between 9.0 and 11.0 mg glucose-free bupivacaine, and the anaesthetic efficacy of an additional 2.0 mg bupivacaine vs 20 µg fentanyl.
METHODS
Local Ethics Committee approval was obtained for the study and written informed consent was obtained for each patient. Patients with a fractured neck of femur requiring internal fixation with a dynamic hip screw (DHS) or a hemiarthroplasty, and who were over 70 years of age and under 70 kg estimated body weight, were eligible for enrolment.
Patients were randomly allocated to receive one of two spinal solutions, either 9.0 mg glucose-free bupi-vacaine+20 µg fentanyl (the study solution, BF), or 11.0 mg glucose-free bupivacaine without fentanyl (the standard solution, B). The syringes were prepared by Baxter Healthcare under sterile conditions and contained the same volume, 2.2 ml. The specific gravity of the standard solution B and the study solution BF were measured by Baxter at 37°c and were 1.006085 and 1.00534 respectively. These values equate to baricities of 0.9992 and 0.9984 respectively, at 37°, indicating that solution B was essentially isobaric and solution BF was slightly hypobaric 4 .
Each syringe was assigned a computer-generated random number by the hospital pharmacy. They were administered in numerical order to each patient in turn. The administering anaesthetists and the patients were blinded to the syringe contents. Patients were not premedicated and were transported into the operating theatre on their ward bed. Reliable intravenous access was obtained. Monitoring was applied using a Datex S5 monitor (Datex-Engstrom, Helsinki, Finland) and baseline measurements of non-invasive systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MBP), heart rate (HR), respiratory rate (RR) and pulse oximetry (SpO 2 ) were obtained prior to patient positioning or drug administration. Three SBP readings within 5% of each other were required before taking the average of these as the baseline SBP.
Prior to positioning, patients inhaled nitrous oxide (N 2 O) 70% and oxygen (O 2 ) 30% for several minutes to provide analgesia. In addition, they were given midazolam (0.5 mg boluses) at the discretion of the anaesthetist. Patients were then turned onto their side on their ward bed with the fractured hip uppermost, for insertion of the spinal block. The N 2 O was then ceased and O 2 administered through a face mask at six litres per minute for the rest of the procedure.
The spinal block was performed with a 22 gauge spinal needle at the L3-4 interspace, or failing that, at the L2-3 interspace. After injection, patients were left on their side for one minute and then transferred onto the operating table. Those having a DHS were positioned supine, and those having a hemiarthroplasty remained on their side. An attempt was made to ascertain the sensory height of the block with ice before the onset of surgery but this was often difficult due to the high incidence of dementia in this patient population.
All patients were given 8 ml/kg of intravenous (IV) Hartmann's solution over 10 to 15 minutes once the spinal drugs had been administered. Subsequent IV Hartmann's was given at the discretion of the attending anaesthetist, to compensate for blood loss.
SBP, DBP, MBP, SpO 2 , HR and RR were measured every three minutes, from the time of injection of spinal drugs for one hour in the case of a DHS, and for one hour or until insertion of cement, in the case of a hemiarthroplasty. Hypotension was defined as a fall in SBP of more than 25% from baseline or to less than 90 mmHg. Each episode of hypotension was treated with a 0.25 mg bolus of metaraminol IV. The number of episodes of hypotension, the number of metaraminol doses and the total dose of metaraminol were recorded for each patient.
Throughout the operative procedure, patients were observed for signs of discomfort, agitation, pruritus, nausea, vomiting, and sedation. Discomfort was treated with ketamine 20 mg repeated as necessary. Pruritus was considered present if patients reported it when questioned or if they scratched their nose, face or chest during the procedure. Midazolam 0.5 mg IV boluses were given for agitation at the discretion of the anaesthetist. The time from injection of spinal drugs to the onset of surgery, the surgery time and the estimated blood loss and volume of Hartmann's solution administered at one hour or cement insertion were recorded.
Patients were observed postoperatively for 60 minutes in the recovery room where they were monitored by nursing staff who were also unaware of study group allocation. SBP was recorded every five minutes and patient pain assessed at 30 and 60 minutes with a verbal rating score from 0 to 10. Patients were again observed for nausea, vomiting, pruritus and sedation. Oxygen at 6 l/min via face mask was continued in the recovery room and at 2 to 3 l/min via nasal prongs for 12 to 24 hours postoperatively on the ward.
To detect a difference of two episodes of hypotension between groups B and BF, a power analysis determined that each group should have at least 14 subjects (alpha 0.05, beta 0.1). Twenty patients were subsequently enrolled in each group, on an "intention to treat" basis. Statistical tests used were the t-test for continuous data and the chi-squared test for comparison of proportions (Fisher Exact test for cell sizes less than 5), as indicated in the results table. A P value <0.05 was regarded as significant.
RESULTS
Patient demographics were similar in each group and there was no significant difference in baseline blood pressures (Table 1) .
Four patients in group BF did not achieve ade- quate spinal anaesthesia and were considered to have failed blocks. In two patients (1 DHS, 1 hemiarthroplasty) insertion of the spinal was difficult, and in the other two DHS patients, insertion was uneventful. These patients were given supplemental IV ketamine, allowing surgery to proceed. In group B, one DHS patient had a failed block after uneventful insertion and was also given IV ketamine. Additionally, in group B, one hemiarthroplasty patient experienced discomfort nearly 2 hours after block insertion, and another hemiarthroplasty patient experienced pain during closure of the top end of the wound, again nearly two hours after block insertion. The rates of failed spinal and discomfort in the two groups were not statistically different. The groups were similar for other intraoperative parameters ( Table 2 ).
In many patients it was not possible to measure the block height prior to the onset of surgery due to the presence of dementia. In those who could be tested, there was a large variation in block height, from L3 to T5 in group BF, and from T12 to T6 in group B.
The incidence and frequency of hypotension, as defined, was less in group BF than in group B. There were greater falls in systolic, diastolic and mean blood pressures, compared to baseline in group B. There was a trend towards higher metaraminol use in group B (Table 3) .
In group B, the number of metaraminol doses was less than the number of hypotensive episodes, because in one patient, with hypotension as defined, administration of metaraminol was considered inappropriate by the investigator due to the patient having an elevated diastolic blood pressure and heavier than usual bleeding.
Recovery room observations were similar in each group (Table 4 ).
DISCUSSION
We achieved less hypotension under spinal anaesthesia by using a reduced dose of glucose-free bupivacaine with fentanyl compared with a higher dose of glucose-free bupivacaine alone. With a smaller dose of bupivacaine, there was presumably less sympathetic blockade and hence less hypotension. Fentanyl should not contribute to autonomic blockade 3 .
A small number of studies in hip fracture patients have looked at prevention of hypotension by combining local anaesthetic with fentanyl. Ben-David et al 5 used a "minidose" of 4 mg glucose-free bupivacaine in combination with 20 µg fentanyl to reduce hypotension compared with 10 mg glucose-free bupivacaine alone (both 2.0 ml). They achieved adequate blocks in all patients, however our local experience was that these solutions resulted in inadequate blocks in our patients. We found that the minimum dose of glucose-free bupivacaine alone that was required to produce an adequate block was 11.0 mg, and that when mixed with 20 µg fentanyl, the minimum dose required was 9.0 mg. Hence these became our standard and study solutions in this formal assessment. This difference in requirements perhaps reflects differences in Ben-David's and our populations. In a study using hyperbaric bupivacaine 6 , it was found that 7.5 mg bupivacaine with 20 µg fentanyl did not reduce hypotension compared with 12.5 mg bupivacaine alone (both 2.5 ml). The authors concluded that in the supine position, hyperbaric solutions migrate cephalad under the influence of gravity, and cause sympathetic block, even in reduced concentration. Isobaric solutions (glucose-free bupivacaine) will not spread under the influence of gravity and block height will depend on the level of injection and the spread obtained with mixing in the CSF. Hence we used glucose-free bupivacaine in this study.
Carpenter et al 7 have determined that lumbosacral cerebrospinal fluid (CSF) volume is the primary determinant of sensory block height with smaller CSF volumes resulting in higher block heights. However CSF volume was found to be very variable. Using magnetic resonance imaging (MRI) to measure CSF volume in volunteers aged 28 to 42, they found a range in volumes of 42 to 81 ml, and observed that variations in CSF volume were not easily predicted by patient characteristics (gender, age, height and weight). Similarly, Hogan et al 8 found a 3.6 fold variability in CSF volumes in healthy volunteers aged 27 to 43 years.
The patients in our study were much older and it is not known if a similar variability in CSF volume exists in the elderly. A wide range of sensory block heights was observed in those who could be assessed, consistent with this concept. Wide variability of sympathetic block height would also be anticipated, and might have been expected to override any haemodynamic benefit incurred by a reduction of 2.0 mg bupivacaine in group BF. Nevertheless hypotension was reduced in this group, presumably because despite variability in block height, the intensity of sympathetic block was decreased by the dilutional effect of the fentanyl on the concentration of bupivacaine.
Although there was no significant difference in the incidence of failed spinals or mild discomfort in the two groups, the study may have had insufficient power to detect a small difference. There was a trend towards better anaesthetic efficacy with an extra 2.0 mg bupivacaine vs 20 µg fentanyl, however neither solution was shown to be ideal. Two failed spinals in group BF followed difficult insertions, and it is possible that the spinal solutions were deposited in suboptimal locations, such as into a sleeve of dura around a nerve root, resulting in inadequate spinal spread. The other two failures in group BF and the one failure in group B followed uneventful insertion. A possible cause may have been inadvertent low injection of the spinal solution, although inadvertent high injection is more likely than low injection 9 . Alternatively, the failures may relate to larger lumbosacral CSF volumes in these patients, indicating that the volume (2.2 ml in each group) and dose of spinal anaesthetic injected was not sufficiently large for all patients. In either case, a reduced sensory block height and failure of adequate anaesthesia could result. One could postulate that in our patient population, a solution comprising 10 mg glucose-free bupivacaine and 20 µg fentanyl might be more ideal by improving block success rate while maintaining some haemodynamic advantages.
Our patients were administered 8 ml/kg of crystalloid with the onset of the spinal block as recommended in the review by Critchley 1 . Hypotension was treated with 0.25 mg boluses of metaraminol, as recommended by Critchley et al 10 . Twenty micrograms of subarachnoid fentanyl has been shown to be safe and not cause respiratory depression in the elderly 5, 6, 11 . Respiratory rates were not depressed in either group in our study, although it was common for SpO 2 in both groups to drop below 96% in the recovery room. This probably reflects the general frailty of our patients. There were no other side-effects attributable to subarachnoid fentanyl.
In conclusion, we showed that the incidence and frequency of systolic hypotensive episodes, and falls in systolic, diastolic and mean blood pressures relative to baseline, were reduced by using 9.0 mg of glucose-free bupivacaine with 20 µg fentanyl compared to 11.0 mg glucose-free bupivacaine alone.
